WHO于20世纪70年代提出的基本药物概念已经得到广泛认可,世界上大多数国家根据WHO的基本药物示范目录制定了本国的基本药物目录,并在国家卫生政策中优先保障基本药物的可及性。中国是最早接受WHO基本药物概念的国家之一,并从20世纪80年代开始制定国家基本药物目录。中国的基本药物目录在国家卫生政策与医疗保障政策中起到了重大的作用,然而基本药物制度并不完善,特别是当前中国卫生制度的许多重要方面也不利于基本药物可及性的提高和促进基本药物的合理使用,亟待在新一轮的医改中解决这些问题。本报告旨在通过国内外基本药物政策分析,结合理论探讨,为中国的基本药物制度建设提供一些政策依据。
<<The idea of Essential Medicines (EMs) introduced by WHO in 1970’s has been accepted globally,based on which most countries have established their own essential medicine lists (EML) as to increase the access to these medicines. China began to frame its EML in 1980s and since then EML has took a key role in the fields of public health and medical insurance. However,the problems of lack of accessibility to the EMs and irrational use are still common in China. Improving the system of essential medicines is one of the hot topics in this round of health system reform. Based on the theoretical exploration and policy analysis of several national essential medicine systems,this report aims to provide some background information for the framework of essential medicines policy in China.
<<Keywords: | SystemPolicyEssential Medicines |